Dasatinib induces severe hemorrhagic colitis in a patient with accelerated phase of chronic myelogenous leukemia

키워드

참고문헌 (5)

1. Talpaz M, "Dasatinib in imatinib-resistant Philadelphia chromosome-positive leukemias", N Engl J Med, 354, pp.2531~2541 (2006)[DOI]
2. Kostos L, "Gastrointestinal bleeding in a chronic myeloid leukaemia patient precipitated by dasatinib-induced platelet dysfunction: case report", Platelets, 26, pp.809~811 (2015)[DOI]
3. Quintas-Cardama A, "Tyrosine kinase inhibitor-induced platelet dysfunction in patients with chronic myeloid leukemia", Blood, 114, pp.261~263 (2009)[DOI]
4. Gratacap MP, "The new tyrosine- kinase inhibitor and anticancer drug dasatinib reversibly affects platelet activation in vitro and in vivo", Blood, 114, pp.1884~1892 (2009)[DOI]
5. Kmira Z, "Severe hemorrhagic colitis in a patient with chronic myeloid leukemia in the blastic phase after dasatinib use", World J Gastrointest Pathophysiol, 4, pp.59~62 (2013)[DOI]

관련 논문AI추천